Thursday, September 28, 2017, 11:00 a.m. to 12:00 p.m. PT.
We’re pleased to invite you to join Office of Disease Prevention and Health Promotion (ODPHP) for a webinar about reducing the rates of adverse drug events.
Adverse drug events (ADEs) are injuries caused by medical interventions related to a pharmaceutical drug. They include medication errors, adverse drug reactions, allergic reactions, and overdoses. Two out of 3 ADEs are related to 3 specific types of drugs: anticoagulants, diabetes, and opioids.
ADEs are a significant cause of injury to patients. In inpatient settings, they affect about 2 million hospital stays each year. They’re also responsible for an annual 3.5 million visits to the doctor.
Recently, the U.S. Department of Health and Human Services approved new measures for tracking ADEs, which include 2020 target goals for reducing ADEs. Implementation of these measures is based on the National Action Plan for Adverse Drug Event Prevention (ADE Action Plan)
During this webinar, presenters will:
- Explain how and why the ADE Action Plan was created
- Provide a look at 2020 targets and measures
- Discuss inpatient and outpatient data collection
- Describe strategies for addressing ADEs caused by each type of drug (opioids, anticoagulants, and diabetes agents)
- Introduce new quality payment incentives from the Centers for Medicare & Medicaid Services
- Contact Us
- Medicare Quality Improvement (QIO)
- Join the HSAG HQIC Partnership
- ESRD Networks Home
- Pharmacy and Quality Measurement Division
- Medicaid External Quality Review
- Quality Payment Program Service Center
- Audit and Validation Services (HEDIS®/P4P)
- HSAG HIIN